May 11, 2015—Global spending on cancer treatment and support medicines reached $100 billion in 2014, up from $75 billion five years earlier, the IMS Institute for Healthcare Informatics reports.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)